Boehringer Ingelheim and Lilly Announce an Academic Collaboration with
University of Oxford to assess effect of empagliflozin on heart and kidney d...
2018-04-17
文传商讯
Cyltezo, adalimumab biosimilar from Boehringer Ingelheim, approved in E
The European Commission has granted marketing authorisation for a biosimilar...
2017-11-15
文传商讯
Boehringer Ingelheim receives positive CHMP opinion for adalimumab bios
Committee for Medicinal Products for Human Use (CHMP) of the European Medici...
2017-09-19
文传商讯
